Flächentarifvertrag und Tarifpartnerschaft in Deutschland: ein historischer Rückblick H Lesch, D Byrski IW-Analysen, 2016 | 19* | 2016 |
Market size and research: Evidence from the pharmaceutical industry D Byrski, F Gaessler, MJ Higgins National Bureau of Economic Research, 2021 | 13 | 2021 |
IP-based incentives against antimicrobial crisis: a European perspective PHD Batista, D Byrski, M Lamping, R Romandini IIC-International Review of Intellectual Property and Competition Law 50, 30-76, 2019 | 9 | 2019 |
Marketing Authorization and Strategic Patenting: Evidence from Pharmaceuticals D Byrski, LX Wang | 1 | 2024 |
Study on the legal aspects of Supplementary Protection Certificates in the EU. Final report R Romandini, A Kur, A Walz, L Valtere, PR Slowinski, G Wright, ... European Commission, 2018 | 1 | 2018 |
Marketing Authorization, Patentability Standards, and Strategic Patenting: Evidence from Pharmaceuticals LX Wang, D Byrski, T Beleche ASHEcon 2024 Conference, 2024 | | 2024 |
Marketing Authorization, Patentability Standards, and Strategic Patenting: Evidence from Pharmaceuticals D Byrski, LX Wang Patentability Standards, and Strategic Patenting: Evidence from …, 2023 | | 2023 |
From Scientific Research to Healthcare Markets: Empirical Essays on the Economics of Pharmaceutical Innovation D Byrski | | 2021 |
Scientific Production: An Exploration into Organization, Resource Allocation, and Funding J Thursby, M Thursby, KR Lakhani, KR Myers, N Cohodes, S Bratt, ... https://www.hbs.edu/faculty/Pages/item.aspx?num=59245, 2020 | | 2020 |
Fire and Mice: The Effect of Supply Shocks on Basic Science SH Baruffaldi, D Byrski, F Gaessler Academy of Management Proceedings 2020 (1), 14405, 2020 | | 2020 |